Prognostic Impact of Minimal Residual Disease in<i>CBFB-MYH11</i>–Positive Acute Myeloid Leukemia
Andrea Corbacioglu(Düsseldorf University Hospital), Konstanze Döhner(University Hospital Ulm), Lars Bullinger(Stanford University), Claudia Scholl(German Cancer Research Center), Karina Eiwen(Johannes Gutenberg University Mainz), Richard F. Schlenk(German Cancer Research Center), David Nachbaur(Innsbruck Medical University), Mathias Rummel(Universitätsklinikum Gießen und Marburg), Juan Du(Essen University Hospital), Hartmut Döhner(University Hospital Ulm), Peter Reimer(Essen University Hospital), Jürgen Krauter(Klinikum Braunschweig), Stefan Fröhling(German Cancer Research Center), Hans‐Günter Derigs(Essen University Hospital), Arnold Ganser(Medizinische Hochschule Hannover)
Cited by 136
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k